What are the first-line treatment options for patients diagnosed with non-squamous non-small cell lung cancer?
Abstract
First-line treatment options for non-squamous NSCLC include combinations of immunotherapy with chemotherapy, particularly pembrolizumab or atezolizumab, and for high PD-L1 expression, single-agent pembrolizumab is considered. Molecular testing is essential to guide therapy decisions.
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026